Ozanimod Capsules Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 0.92 mg
Reference Brands: Zeposia(US & EU)
Category:
Multiple sclerosis
Ozanimod is a selective S1P receptor modulator that inhibits lymphocyte migration, reducing inflammation in autoimmune diseases. It decreases relapse rates and disease activity in multiple sclerosis and ulcerative colitis. Benefits include oral administration, targeted immune regulation, fewer relapses, and improved quality of life for patients with chronic inflammatory conditions.
Ozanimod Capsules is available in Capsules
and strengths such as 0.92 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ozanimod Capsules is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ozanimod Capsules can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ozanimod capsules, marketed as Zeposia, are approved in the US by the FDA and in the EU via EMA for relapsing multiple sclerosis and ulcerative colitis. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing processes, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality data, while the EMA ensures compliance with regional standards for safety and manufacturing.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing